Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer

Clinical trial NCT02685267 · TERMINATED

Trial details

NCT number: NCT02685267
Sponsor: Prostate Cancer Clinical Trials Consortium
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2016-02-01
Primary completion: 2017-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.